Compound Description
| ID: C0387 | Common name: Sanggenon G |
| IUPAC: (2S)-6-[(1S,5R,6S)-6-(2,4-dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-(4-methylpent-3-enyl)cyclohex-2-en-1-yl]-2-(2,5-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydrochromen-4-one | CAS: CAS:85698-31-3 |
| Chembl ID: CHEMBL382338 | Pubchem ID: CID:44408701 |
| Formula: C40H38O11 | TCM-ID: TCMC2043 |
| Smiles: CC(=CCCC1=C[C@H](c2c(O)cc3c(c2O)C(=O)C[C@H](O3)c2cc(O)ccc2O)[C@H]([C@@H](C1)c1ccc(cc1O)O)C(=O)c1ccc(cc1O)O)C | |
| Alias:
4H-1-Benzopyran-4-one, 6-[(1S,5R,6S)-6-(2,4-dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-(4-methyl-3-pentenyl)-2-cyclohexen-1-yl]-2-(2,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-, (2S)-;
4H-1-Benzopyran-4-one, 6-[6-(2,4-dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-(4-methyl-3-pentenyl)-2-cyclohexen-1-yl]-2-(2,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-, [1S-[1α(R*),5α,6β]]-; (2S)-6-[(1S,5R,6S)-6-(2,4-Dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-(4-methyl-3-penten-1-yl)-2-cyclohexen-1-yl]-2-(2,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-4H-1-benzopyran-4-one; Sanggenon G; Sanggenone G |
Structure:
|
Related Targets (Total: 1)
| Target id | Protein Name | Gene Symbol | Uniprot ID | Target Level | No.of Literature Evidence |
|---|---|---|---|---|---|
| T14LSK | E3 ubiquitin-protein ligase XIAP | XIAP |
P98170 |
A | 1 Reference(s) |
*In this table, target level represents the quality confidence indicators of targets.
Level 'A' represents "Directly inhibit/activate".
Level 'B' represents "Indirectly inhibit/ activate", "Enzyme substate" and "Enzyme product".
Level 'C' represents "Up/Down regulation" and "Others".
Level 'A' represents "Directly inhibit/activate".
Level 'B' represents "Indirectly inhibit/ activate", "Enzyme substate" and "Enzyme product".
Level 'C' represents "Up/Down regulation" and "Others".
Related Herbs (Total: 3)
Ckey description of the interaction between compound and target